Natural history of focal nodular hyperplasia of the liver: An ultrasound study
β Scribed by Di Stasi, Michele; Caturelli, Eugenio; De Sio, Ilario; Salmi, Andrea; Buscarini, Elisabetta; Buscarini, Luigi
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 708 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
β¦ Synopsis
Sixteen cases of focal nodular hyperplasia (FNH) of the liver were followed by ultrasound (US) for a mean of 33 months (range 6-81). In 69% of the cases, the diagnosis was incidental. On US the lesions were single in 75% of the cases, localized in the right lobe in 75%, and subcapsular in 50%. No specific US-pattern could be identified. A central scar was found in 19% of the patients. At the end of the follow-up, the size was reduced in 7/16 cases, and in 1/16 the lesion disappeared. The spontaneous reduction of nodules in FNH must be considered in the management of this pseudotumor.
π SIMILAR VOLUMES
Focal nodular hyperplasia (FNH) of the liver is a benign tumor commonly considered as a reactive disorder related to a pre-existing vascular malformation. However, the pathogenesis of this lesion has been recently discussed. To determine whether FNH is a polyclonal or a clonal lesion, we investigate
## Abstract ## Purpose. We aimed to investigate the natural course of hepatic focal nodular hyperplasia (FNH) in a longβterm followβup study with sonography. ## Method. This study comprised 30 patients (24 women and 6 men) with 34 FNHs. Diagnosis of FNH was made using color Doppler sonography, c
A 48-year-old woman is described with a pancreatic islet cell carcinoma that had no clinical evidence of hormone production. This neoplasm was removed by radical distal pancreatectomy . Immunohistochemical and extraction studies performed on the tumor tissue revealed that it was producing serotonin
## Abstract Portal hypertension has been described in a wide variety of hematological disorders, especially myeloproliferative and lymphoproliferative disorders. Its clinical manifestations may include bleeding esophageal varices, ascites, or hepatic encephalopathy. In patients with hematological d